Edwin Wagena

1.5k total citations
25 papers, 995 citations indexed

About

Edwin Wagena is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Speech and Hearing. According to data from OpenAlex, Edwin Wagena has authored 25 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 14 papers in Pulmonary and Respiratory Medicine and 4 papers in Speech and Hearing. Recurrent topics in Edwin Wagena's work include Smoking Behavior and Cessation (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers) and Asthma and respiratory diseases (9 papers). Edwin Wagena is often cited by papers focused on Smoking Behavior and Cessation (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers) and Asthma and respiratory diseases (9 papers). Edwin Wagena collaborates with scholars based in Netherlands, Taiwan and United States. Edwin Wagena's co-authors include C.P. van Schayck, Emiel F.�M. Wouters, P. Knipschild, Raymond Ostelo, James B. Kaper, Marc C. Willemsen, Marcus J. H. Huibers, Willem A. Arrindell, Constant P. van Schayck and Ludovic G. P. M. van Amelsvoort and has published in prestigious journals such as Blood, Cochrane Database of Systematic Reviews and European Respiratory Journal.

In The Last Decade

Edwin Wagena

25 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin Wagena Netherlands 20 622 460 203 150 129 25 995
David Tinkelman United States 19 777 1.2× 452 1.0× 158 0.8× 100 0.7× 40 0.3× 48 1.1k
Åke Westin Sweden 13 943 1.5× 176 0.4× 72 0.4× 295 2.0× 309 2.4× 17 1.1k
Elisa K. Tong United States 20 1.7k 2.7× 565 1.2× 257 1.3× 234 1.6× 45 0.3× 73 2.2k
LF Stead United Kingdom 15 1.1k 1.7× 167 0.4× 293 1.4× 429 2.9× 250 1.9× 21 1.5k
Eva Králíková Czechia 18 576 0.9× 69 0.1× 157 0.8× 236 1.6× 167 1.3× 89 996
Rebecca E. Schane United States 7 497 0.8× 143 0.3× 154 0.8× 196 1.3× 38 0.3× 8 823
Chester Pabiniak United States 16 273 0.4× 314 0.7× 228 1.1× 194 1.3× 45 0.3× 23 1.5k
Jonathan Livingstone‐Banks United Kingdom 21 1.2k 2.0× 123 0.3× 286 1.4× 458 3.1× 185 1.4× 53 1.6k
Katie Myers Smith United Kingdom 18 1.4k 2.2× 141 0.3× 126 0.6× 623 4.2× 222 1.7× 36 1.8k

Countries citing papers authored by Edwin Wagena

Since Specialization
Citations

This map shows the geographic impact of Edwin Wagena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Wagena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Wagena more than expected).

Fields of papers citing papers by Edwin Wagena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Wagena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Wagena. The network helps show where Edwin Wagena may publish in the future.

Co-authorship network of co-authors of Edwin Wagena

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Wagena. A scholar is included among the top collaborators of Edwin Wagena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Wagena. Edwin Wagena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srivastava, Alok, Chris Mason, Edwin Wagena, et al.. (2015). Part 1: Defining unproven cellular therapies. Cytotherapy. 18(1). 117–119. 31 indexed citations
2.
Schayck, Constant P. van, et al.. (2011). Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation. Addiction. 107(1). 178–187. 16 indexed citations
3.
Schayck, Constant P. van, et al.. (2009). The cost‐effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. Addiction. 104(12). 2110–2117. 16 indexed citations
4.
Wagena, Edwin, et al.. (2008). The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: Results of a randomized, placebo-controlled phase 1/2 trial. Nicotine & Tobacco Research. 10(1). 213–218. 36 indexed citations
5.
Kotz, Daniel, Edwin Wagena, & Geertjan Wesseling. (2006). Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians. Respiratory Medicine. 101(3). 568–573. 32 indexed citations
6.
Kaper, James B., Edwin Wagena, Marc C. Willemsen, & C.P. van Schayck. (2006). A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence. Addiction. 101(11). 1656–1661. 28 indexed citations
7.
Kaper, James B., Edwin Wagena, Constant P. van Schayck, & Johan L. Severens. (2006). Encouraging Smokers to Quit. PharmacoEconomics. 24(5). 453–464. 29 indexed citations
8.
Wagena, Edwin & P. Knipschild. (2005). Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?. Journal of Medical Ethics. 31(5). 307–307. 4 indexed citations
9.
Wagena, Edwin. (2005). The scandal of unfair behaviour of senior faculty. Journal of Medical Ethics. 31(5). 308–308. 23 indexed citations
10.
Wagena, Edwin, Willem A. Arrindell, Emiel F.�M. Wouters, & C.P. van Schayck. (2005). Are patients with COPD psychologically distressed?. European Respiratory Journal. 26(2). 242–248. 127 indexed citations
11.
Wagena, Edwin, P. Knipschild, & Maurice P. Zeegers. (2005). Should nortriptyline be used as a first‐line aid to help smokers quit? Results from a systematic review and meta‐analysis. Addiction. 100(3). 317–326. 46 indexed citations
12.
Wagena, Edwin, P. Knipschild, Marcus J. H. Huibers, Emiel F.�M. Wouters, & C.P. van Schayck. (2005). Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease. Archives of Internal Medicine. 165(19). 2286–2286. 109 indexed citations
13.
Kaper, James B., Edwin Wagena, Marc C. Willemsen, & C.P. van Schayck. (2005). Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction. 100(7). 1012–1020. 70 indexed citations
14.
Wagena, Edwin, Ludovic G. P. M. van Amelsvoort, IJmert Kant, & Emiel F.�M. Wouters. (2005). Chronic Bronchitis, Cigarette Smoking, and the Subsequent Onset of Depression and Anxiety: Results From a Prospective Population-Based Cohort Study. Psychosomatic Medicine. 67(4). 656–660. 56 indexed citations
15.
Wagena, Edwin, et al.. (2004). The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review. Respiratory Medicine. 98(9). 805–815. 75 indexed citations
16.
Wagena, Edwin, IJmert Kant, Ludovic G. P. M. van Amelsvoort, et al.. (2004). Risk of Depression and Anxiety in Employees With Chronic Bronchitis: The Modifying Effect of Cigarette Smoking. Psychosomatic Medicine. 66(5). 729–734. 34 indexed citations
17.
Wagena, Edwin, IJmert Kant, Marcus J. H. Huibers, et al.. (2004). Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: A population-based observational study on prevalence and the relationship with smoking cigarettes. European Journal of Epidemiology. 19(2). 147–153. 33 indexed citations
18.
Willemsen, Marc C., Edwin Wagena, & C.P. van Schayck. (2003). [The efficacy of smoking cessation methods available in the Netherlands: a systematic review based on Cochrane data].. PubMed. 147(19). 922–7. 28 indexed citations
19.
Wagena, Edwin, et al.. (2003). Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease. Drug Safety. 26(6). 381–403. 25 indexed citations
20.
Wagena, Edwin, Marcus J. H. Huibers, & C.P. van Schayck. (2001). Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression. Thorax. 56(8). 587.2–588. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Tinkelman Breakdown of academic impact, for papers by Åke Westin Breakdown of academic impact, for papers by Elisa K. Tong Breakdown of academic impact, for papers by LF Stead Breakdown of academic impact, for papers by Eva Králíková Breakdown of academic impact, for papers by Rebecca E. Schane Breakdown of academic impact, for papers by Chester Pabiniak Breakdown of academic impact, for papers by Jonathan Livingstone‐Banks Breakdown of academic impact, for papers by Katie Myers Smith
Rankless by CCL
2026